• Online Features  This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (32)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Neurology  • Multiple Sclerosis/ Demyelinating Disease  • Immunologic Disorders  • Alert me on articles by topic  Social Bookmarking   What's this?

Potential Implications for Future Therapies

Jaime Imitola, MD; Tanuja Chitnis, MD; Samia J. Khoury, MD

Arch Neurol. 2006;63:25-33.

Despite recent advances in the diagnosis and treatment of multiple sclerosis, we still lack a consensus regarding the causes, pathogenesis, and mechanisms of disease progression. Current evidence indicates that multiple sclerosis is an inflammatory neurodegenerative disorder in which both adaptive and innate immunity play important roles in initiation and maintenance of the disease. Recent evidence supports the notion of molecular pathologic abnormalities beyond the plaques and dysfunction of neurons in normal appearing areas, in addition to the multifocal demyelination and axonal loss, as important features that may underlie early reversible changes in the disease. Chronic failure of remyelination, axonal regeneration, and neuronal dysfunction may contribute to disease progression. This article discusses the emerging molecular evidence for the progression of multiple sclerosis with particular focus on alterations in the local central nervous system microenvironment of neural and glial cells. The molecular pathways leading to structural and functional neurodegeneration and those that prevent regeneration need to be identified in order to design new therapeutic strategies that can halt or even reverse disease progression.

Author Affiliations: Center for Neurologic Diseases and Partners Multiple Sclerosis Center, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass.

CiteULike    Connotea    Delicious    Digg    Facebook    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Effect of optic neuritis on progressive axonal damage in multiple sclerosis patients
Garcia-Martin et al.
Mult Scler 2011;17:830-837.
ABSTRACT | FULL TEXT  

A Novel Unbiased Proteomic Approach to Detect the Reactivity of Cerebrospinal Fluid in Neurological Diseases
Menon et al.
Mol. Cell. Proteomics 2011;10:M110.000042-M110.000042.
ABSTRACT | FULL TEXT  

Measuring Myelin Repair and Axonal Loss with Diffusion Tensor Imaging
Fox et al.
Am. J. Neuroradiol. 2011;32:85-91.
ABSTRACT | FULL TEXT  

New perspectives in the natural history of multiple sclerosis
Tremlett et al.
Neurology 2010;74:2004-2015.
ABSTRACT | FULL TEXT  

Comparison of multifocal visual evoked potential, standard automated perimetry and optical coherence tomography in assessing visual pathway in multiple sclerosis patients
Laron et al.
Mult Scler 2010;16:412-426.
ABSTRACT  

Retinal nerve fiber layer atrophy is associated with physical and cognitive disability in multiple sclerosis
Toledo et al.
Mult Scler 2008;14:906-912.
ABSTRACT  

Axonal loss in the retinal nerve fiber layer in patients with multiple sclerosis
Pueyo et al.
Mult Scler 2008;14:609-614.
ABSTRACT  

Natural history of secondary-progressive multiple sclerosis
Tremlett et al.
Mult Scler 2008;14:314-324.
ABSTRACT  

Myeloperoxidase-targeted imaging of active inflammatory lesions in murine experimental autoimmune encephalomyelitis
Chen et al.
Brain 2008;131:1123-1133.
ABSTRACT | FULL TEXT  

Persistent activation of microglia is associated with neuronal dysfunction of callosal projecting pathways and multiple sclerosis-like lesions in relapsing remitting experimental autoimmune encephalomyelitis
Rasmussen et al.
Brain 2007;130:2816-2829.
ABSTRACT | FULL TEXT  

What Causes Multiple Sclerosis to Worsen?
Phillips
Arch Neurol 2007;64:167-168.
FULL TEXT  

Innate Immunity in Multiple Sclerosis: Myeloid Dendritic Cells in Secondary Progressive Multiple Sclerosis Are Activated and Drive a Proinflammatory Immune Response
Karni et al.
J. Immunol. 2006;177:4196-4202.
ABSTRACT | FULL TEXT